Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis

Author： Schmidt J.

Publisher： Oxford University Press

ISSN： 1460-2156

Source： Brain, Vol.126, Iss.8, 2003-08, pp. : 1895-1904

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis

By Opdenakker G. Nelissen I. Van Damme J.

Lancet Neurology, Vol. 2, Iss. 12, 2003-12 ,pp. : 747-756

Elsevier

Access to resources Recommend Favorite

Therapeutic efficacy of EGb761 (Gingko biloba extract) in a transgenic mouse model of amyotrophic lateral sclerosis

By Ferrante Robert Klein Autumn Dedeoglu Alpaslan Flint Beal M.

Journal of Molecular Neuroscience, Vol. 17, Iss. 1, 2001-08 ,pp. : 89-96

Humana Press, Inc

Access to resources Recommend Favorite

Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis

By Linker Ralf A.

Brain, Vol. 133, Iss. 8, 2010-08 ,pp. : 2248-2263

Oxford University Press

Access to resources Recommend Favorite

Impact of fatigue on the efficacy of rehabilitation in multiple sclerosis

By Judica Elda Martinelli Boneschi Filippo Ungaro Daniela Comola Mauro Gatti Roberto Comi Giancarlo Rossi Paolo

Journal of Neurology, Vol. 258, Iss. 5, 2011-05 ,pp. : 835-839

Springer Publishing Company

Access to resources Recommend Favorite

Predicting a window of therapeutic opportunity in multiple sclerosis

By Andersen Oluf

Brain, Vol. 133, Iss. 7, 2010-07 ,pp. : 1863-1865

Oxford University Press

Access to resources Recommend Favorite